NI ⚠ major risk AI Humanized AI Processing...

Nivolumab

Generic: Opdivo

Class: Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Source (WebMD)

AI Humanized & Translated

Educational use only

AI Humanized & Translated

Educational use only

AI Humanized & Translated

Educational use only

AI Humanized & Translated

Educational use only

AI Humanized & Translated

Educational use only

Check the conditions that apply to you before taking this medication:

["Before taking this medicine", "To make sure Nivolumab is safe for you, tell your doctor if you:", "have immune system problems such as Crohn\\\\u2019s disease, ulcerative colitis, or lupus\\\\nhave received an organ transplant\\\\nhave liver disease\\\\nhave received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic)\\\\nhave received radiation treatment to your chest area in the past and have received other medicines that are similar to nivolumab\\\\nhave a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barr\\\\u00e9 syndrome\\\\nare pregnant or plan to become pregnant\\\\nare breastfeeding or plan to breastfeed", "Nivolumab may harm an unborn baby You may need to have a negative pregnancy test before starting this treatment Use effective birth control to prevent pregnancy while receiving nivolumab and for at least 5 months after your last dose Tell your doctor right away if you become pregnant.", "It is not known if nivolumab passes into your breast milk Do not breastfeed while using this medicine, and for at least 5 months after your last dose."]

Talk to your doctor

One or more conditions apply to you. Please consult a healthcare professional before taking this medication.

Quick Safety Summary

Risk Level major

Drug Class Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Generic Name Opdivo

Data Source Unknown

Nivolumab

Cookie Details

Your privacy matters